Cancer Biology & Therapy Journal Citation Rate 2026

ISSN 1538-4047 eISSN 1555-8576 Taylor & Francis US

Approx. Q1 Quartile Open Access Top Tier

About Cancer Biology & Therapy
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Cancer Biology & Therapy (CBT) is an academic journal covering Cancer Cells and Metastasis and Cancer, Hypoxia, and Metabolism, published by Taylor & Francis in US, catalogued under ISSN 1538-4047 (e-ISSN 1555-8576). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 6.11 (approximate Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $2970 USD. OpenAlex records 5,248 works and 169,212 citations, with an h-index of 153.

Cancer Biology & Therapy Citation Rate 2026 — In Context

Cancer Biology & Therapy has a 2025 2-Year Citation Rate (OpenAlex) of 6.11, placing it in the approximate Q1 quartile within the Cancer Cells and Metastasis research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

As a fully open-access publication, Cancer Biology & Therapy makes all articles freely available to readers for an Article Processing Charge of approximately $2970 USD.

Researchers looking to publish in Cancer Biology & Therapy should review the journal's submission tips and check the latest indexing status at the source (the Scopus Sources list, DOAJ and Web of Science); our indexing tracker shows the OpenAlex and DOAJ coverage we hold. To compare Cancer Biology & Therapy against similar journals in the field, use our journal comparison tool.

Submission Tips for Cancer Biology & Therapy
  • Budget $2970 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cancer Biology & … Compares
Citation Rate vs Field Avg
+66%
Field avg: 3.68
APC vs Field Avg
-15%
Field avg: $3475

Compared against 31 journals in the same research areas.

ISSN (Print) 1538-4047
ISSN (Online) 1555-8576
Publisher Taylor & Francis
Country United States
APC / Cost $2970 USD
h-index 163
Total Works 5,236
Total Citations 185,316
2-yr Mean Citedness 6.34 (OpenAlex)
DOAJ Listed
In-depth profile & metrics

Cancer Biology & Therapy is published by Taylor & Francis and based in United States. It publishes open access with an article-processing charge of USD 2970.

In our subject taxonomy, Cancer Biology & Therapy is classified under Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways and Cell death mechanisms and regulation.

Cancer Biology & Therapy is indexed in the DOAJ and OpenAlex. DOAJ lists the journal as open access.

OpenAlex records 5,236 works that have together drawn 185,316 citations, giving the journal an h-index of 163; its most recent citation rate stands at 6.106; OpenAlex puts its two-year mean citedness at 6.34.

Research Areas
Links
Frequently Asked Questions about Cancer Biology & Therapy

Cancer Biology & Therapy does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 6.106 — an open proxy for citation impact, not the licensed JCR Impact Factor.

Yes, Cancer Biology & Therapy is an open access journal.

The Article Processing Charge (APC) for Cancer Biology & Therapy is $2970 USD.

Cancer Biology & Therapy is published by Taylor & Francis.

Cancer Biology & Therapy appears in: OpenAlex. A listing is one signal of a legitimate journal, but it is not proof, and JournalsHub does not verify peer review. Always confirm the journal's peer-review policy, scope and editorial board before submitting.

The ISSN of Cancer Biology & Therapy is 1538-4047. Its electronic ISSN (eISSN) is 1555-8576.

Cancer Biology & Therapy sits in the Q1 quartile based on its latest impact factor of 6.11, ranked across all journals in our database.
OpenAlex and DOAJ Coverage
Updated April 2026

OpenAlex and DOAJ coverage we hold for this journal. Check other databases at the source.

OpenAlex
In OpenAlex
DOAJ
Indexed OA
Predatory Check
Clean
Citation Rate
6.106
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 6.106 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex and DOAJ and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.


Works Published per Year (2014–2025)

Annual publication volume sourced from OpenAlex. Current year omitted (partial data).

Publication & citation history by year
YearWorks publishedCitations received
2025 88 9,299
2024 115 10,194
2023 88 10,741
2022 65 11,146
2021 58 12,256
2020 118 11,792
2019 118 10,302
2018 205 9,460
2017 134 9,852
2016 136 9,501
2015 219 10,014
2014 174 10,270
Journal at a Glance
5,236
Total Works
185,316
Total Citations
163
h-index
6.34
2-Yr Mean Citedness
DOAJ Indexed APC $2970 USD

Source: OpenAlex — refreshed daily.

Top Research Topics

The areas where Cancer Biology & Therapy most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.

Cell death mechanisms and regulation
Biochemistry, Genetics and Molecular Biology
504 works
384 works
Angiogenesis and VEGF in Cancer
Biochemistry, Genetics and Molecular Biology
308 works
Cancer, Hypoxia, and Metabolism
Biochemistry, Genetics and Molecular Biology
293 works
Cancer-related molecular mechanisms research
Biochemistry, Genetics and Molecular Biology
286 works
PI3K/AKT/mTOR signaling in cancer
Biochemistry, Genetics and Molecular Biology
258 works
Prostate Cancer Treatment and Research
Biochemistry, Genetics and Molecular Biology
248 works
Compare Journals

Compare Cancer Biology & Therapy against similar publications in its field:

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S169029442

Get weekly updates for Cancer Cells and Metastasis journals

Free. Monday morning. New citation rates, CFPs, updates on journals you track, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google